Association of FGF-23 and Parathyroid Hormone (PTH) in Dialysis Patients

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
End-Stage Renal Disease
Interventions
PROCEDURE

exposure to a high-calcium dialysate bath

Subjects are exposed to a high calcium (3.5 mEq/L) dialysate bath for 150 minutes (part 1). At defined timepoints (0, 45, 90, and 150 min) blood is sampled for calcium, PTH, phosphorous, and FGF-23. At another (later) dialysis session (part 2), the process is repeated except that the subjects are exposed to a normal calcium bath (2.5 mEq/L). For each subject, results from part 1 are compared to the results from part 2.

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
lead

James B. Wetmore, MD

OTHER

NCT00477516 - Association of FGF-23 and Parathyroid Hormone (PTH) in Dialysis Patients | Biotech Hunter | Biotech Hunter